On the cover
Melasma data strengthens therapeutic insight October 10, 2016By John JesitusAgents that can attack melasma on multiple fronts include retinoids, glucosamine, hydroquinone, topical steroids, phytosterol, glycyrrhetinic acid, niacinamide, soybean extracts, retinoids, salicylic acid and liquirtin, an expert says.
In this issue
There ought to be a wordMy interest in etymology, (not to be confused with entomology) has grown along with the importance of precise and efficient EMR documentation. Along the way, I learned some great words and acronyms and made up a few of my own. Informed consent Is evolving: Now what?Dr. Surgery undertook a weekend blepharoplasty course at a well-respected, nationally recognized occuloplastic surgery program. He has since performed three procedures. Dr. Surgery covered the risks with his patients and received both oral and written consent. His third patient unfortunately suffers the rare complication of retrobulbar hematoma and blindness and sues. Should he be concerned?
Appreciating the role of microbial communities on the skin September 28, 2016By Louise GagnonMicrobial colonization in the development of inflammatory conditions and immune-mediated conditions is a hot research topic, and new dermatologic therapies can potentially result from greater understanding of the role of microbial communities on the skin and in the gut. Trends in tickborne diseases October 10, 2016By Linda Marie WetzelTickborne diseases are a significant health problem in the United States with over 40,000 confirmed or probable cases reported as recently as 2014. Almost 80% of these cases consist of Lyme disease, but other diseases, including viral infections, are present and have been increasing in number over the past 20 years. Experts in tickborne diseases share updates about what’s new and what’s changing in the detection and transmission of these diseases.
8 things about formulating products October 10, 2016By Lisette HiltonSkincare product formulating is a natural for dermatologists, but there are several important considerations before starting what can be an expensive, time-consuming process. Researchers claim global skincare market is growing October 10, 2016By Lisette HiltonA report published by U.S. based market research company Grand View Research suggests the global skincare products market will reach $196.67 billion by 2024, up from an estimated $129.21 billion in 2015. Tackling tough areas with fillers October 12, 2016By John JesitusFilling more challenging areas such as the temples, frontalis, tear trough, jawline and chin can help dermatologists and other core aesthetic specialists stand out among providers of injectable treatments, an expert says.
Study: UV filters interfere with sperm function
September 09, 2016Researchers report in a new in vitro study published in Endocrinology that 13 of the 29 ultraviolet (UV) filters they looked at interfere with sperm function.
Clinical acumen key for identifying pediatric melanomaExperts discuss diagnosis and management of pediatric melanoma, including the latest developments in genetic tools and indications for sentinel lymph node biopsy. Update on advanced basal cell carcinoma diagnosis and treatmentDespite increased insight on skin cancer risk factors, the incidence continues to rise worldwide. This review article summarizes new treatment options available, which help to redefine and expand the diagnosis of advanced BCC and allow dermatologists to offer more effective therapy to a broader population.
Business of Dermatology
Courteous to the core October 10, 2016By John JesitusManaging referrals successfully requires being honest with patients and equitable with peers, experts say. Minding your social media manners October 13, 2016By Cheryl BiseraTen tips for developing a social media marketing policy that will help you avoid pitfalls and stay relevant while giving your practice a glowing social presence and reputation. Moves that could rein in out-of-control drug costs October 13, 2016By Lisette HiltonThe third in our series on out-of-control drug costs highlights strategies that should work to stabilize the costs of medications, so that they’re more affordable for patients.